CA1060031A - Intermediates for prostaglandins - Google Patents

Intermediates for prostaglandins

Info

Publication number
CA1060031A
CA1060031A CA221,374A CA221374A CA1060031A CA 1060031 A CA1060031 A CA 1060031A CA 221374 A CA221374 A CA 221374A CA 1060031 A CA1060031 A CA 1060031A
Authority
CA
Canada
Prior art keywords
group
acid
chloride
give
acetoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA221,374A
Other languages
French (fr)
Inventor
Kenneth G. Paul
Duccio Favara
Francis Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of CA1060031A publication Critical patent/CA1060031A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE
Intermediates for prostaglandins are synthesized from racemic malic acid and enantiomeric d- and l-malic acid derivatives. The novel synthesis of this invention offers the possibility of a stereoselective con-trol of the reaction products to give optically-active derivatives.

Description

1~)6003~ :

BACKGROUND OF THE INVENTION
The prostaglandins are members of a family of hormonal substances which have very potent physiological effects. 4mong these effects, the abortifacient, anti-hypertensive and bronchodilating properties are the most widely investigated, but other important biological actions have been evidenced by several authors. See, for înstance, the review by M.P.L. Caton in "Progress in Medicinal Chemistry" Volume 6, part 2, page 317, edited by G. Ellis and G. B. West, Butterworth & Co., London 1971.
The prostaglandins are optically active derivatives of prostanoic acid, i.e., a substituted cyclopentane com-pound having the following structure:

g 10 ~ 5 4 2 1~ 16 18 20 Although they are naturally occurring in a number of tissues, many chemical approaches to their synthesis have been reported in the literature as their concentration in said tissues is very low.
One of the most convenient approaches to the total che~ical synthesis of prostaglandins is reported by E. J. Corey and coworkers, J. A~. Chem. Soc., 91, 5675 (1969). This approach requires the synthesis of suitable precursors which are derivatives of the lactone of 2-hydroxy-l-cyclopentaneacetic acid. The synthetic pathway reported by E. J. Corey and coworkers in J.A.C.S. ~, 397, 1970 for optically-active prostaglandins as the naturally occurring forms, requires resolution of an intermediate (+)-cyclopentenehydroxy acid by means of (~)-ephedrine salts to obtain the (-)-isomer. The latter is then transformed into the lactone, which is the key compound for a synthetic stereo-controlled route to prostaglandins in the F and E series, i.e., those having oxy functions at positions 9 and 11.
Prostaglandins E may be further transformed into pros-taglandins A according to literature methods.
SUMMARY OF THE INVENTION
This invention concerns a new synthetic route for preparing the lactones of hydroxycyclopentaneacetic acid of the formula ~ I

~ .' RO Rl 106~;)031 and its optically-active forms ~ >~-~ ,_ I 0/ --RO RO R

Ia Ib wherein: R represents an alkanoyl radical of 2 to 8 carbon atoms, e.g., acetyl, propionyl, butyryl, pentanoyl, hexanoyl, heptanoyl, octanoyl, and Rl represents a CH20H group. In the formulas given above and in the specification and claims, the bonds which have the ~-configuration extend behind the plane of the paper and are represented by broken lines, while the bonds which have the ~configur-ation extend out of the plane of the paper and are represented by thickened lines.
10 mus, the invention provides a process for preparing a compound of the group having the formula ~1 RO I R

and its optically active forms O
~J~ F1 r~ ~

Ia Ib wherein R represents an alkanoyl radical of 2 to 8 carbon atoms; and Rl repre-~ 7 ~ -3-' ~,~' , ...... . .

~060031 sents a -CH20H ~rouP; which co~,prises (1) reacting substantially one molar pro-portion of an alkanoyloxy succinoyl chloride with substantially five molar proportions of a salt of the formula [ <COO~] ~ 1 wherein Y represents a -COOR2 group wherein R2 is a lower alkyl and X is a mono-valent magnesium cation selected from the groups Mg BrG~ , MgCl~ and MgI
whereby a 3,6-dioxo-4-acyloxyoctanedioic acid ester is formed, (2) cyclizing the last named by heating it in an aqueous solution at a pH of about 5 to 11 to give a 5-alkanoyloxy-2-carbo(lower alkoxy)-3-oxo-1-cyclopentene-acetic acid ester, (3) hydrogenating the cyclopentene ring to cyclopen~ane and the oxo group to hydroxy, (4) cyclizing the so-obtained alkanoyloxycyclopentaneacetic acid derivative by alkaline hydrolysis and acylation to the corresponding lac-tone of preceding formula I, Ia or Ib wherein Rl is a carboxy group and R is a (C2-C8)alkanoyl, (5) converting the carboxylic group to a mixed anhydride group by reaction with a lower alkyl chlorocarbonate or to an acid chloride group by reaction with SOC12 and (6) reducing the mixed anhydride group or the acid chloride group with excess sodium borohydride to give a gamma lactone of 3-alkanoyloxy-2-hydroxymethyl-5-hydroxycyclopentaneacetic acid.

r~ ,;
, ~ 1~ -3a-, . .

~0160031 The synthetic route of this invention does not require resolution of racemic mixtures when optically-active end compounds are desired, but allows the use of optically active starting materials whose chiral center surprisingly controls the stereochemistry of all the subse-quent reaction steps to afford a predetermined compound of the preceding series Ia or Ib. The process of this invention is a multistep synthesis involving a large number of typical chemical reactions, all of which types are known to those skilled in the art. The pro-cess of this invention lies in the application of these known typical chemical reactions to the proper starting materials under proper conditions to arrive at the desired products.
DESCRIPTIO~ OF TB PREFERRED EMBODIMENTS
The starting material for this synthesis is an anhydride of a malic acid derivative wherein the hydroxy group has been protected by acylation. The series of re-actions involved in this synthesis may be depicted by the following schematic representation which refers to the synthesis of an optically-active end compound and therefore requires the use of optically-active starting materials such as an l-malic acid anhydride derivative represented by following formula II. The use of a racemic or d-malic acid anhydride derivative according to the same reaction scheme and under the same conditions leads, respectively, to an optically inactive end compound or to the enantiomeric mirror image forms.

~060031 o AO~ COOR'¦

II A IIII B

A//~ ~/COOR2AO /~li2-COOR~H -COOR2 o COOR COOR > ooR2 C D
IV V VI

AO,, ~CH2-COOR2 ~\ .
> ~ I o -' HO\~ ~COOR2 ~ _ VII _ .
> o/
VII \ F r' \ H ~;~7 RO COOH
/~ VIII
AcO \CH2-COOR / ~ G

>
-o\\\\ ~ 2 R COOR
X <

RO--~CH2H

10~031 STEP A
In the startine compound II, the symbol A
represents an acyl radical, as previously defined, or a (di-lower alkyl)carbamyl or a (lower alkoxy)carbonyl radical, lower alkyl and lower alkoxy the same as defined above. The preparation of these compounds may be carried out substantially according to the method described in the literature for preparing the anhydride of t~e l-isomer of O-acetylmalic acid; Beilstein, 4th Ed., Vol. 18, page 81 and B. Jones, J. Chem. Soc. 136, 1933, page 788.
The preferred acylating agents for use in the process are acetic acid anhydride, acetyl chloride and benzoyl chloride. The conversion of the anhydride to the acid chloride III is effected by adding to the protected anhydride of l-malic acid an excess of l,l-dichloromethyl methyl ether and anhydrous ZnC12 and refluxine the mix-ture for about 2 to 6 hours. The resulting compound III may be purified by distillation.
STEP B
One molar proportion of the protected l-malic acid chloride III is treated with about five molar pro-portions of a hydrogen malonate salt of the formula indicated above wherein X ~ represents an alkali metal cation or a monovalent magnesium cation selected from the group M~Br ~ , MgCl ~ and MgI ~ , and R represents lower alkyl, as defined, phenyl or benzyl. The temperature ~060031 of the reaction may vary from -30 to +30C. and the reaction time between 5 and 24 hours. The solvent is advanta-geously selected from one of the anhydrous inert organic solvents such as the lower alkyl ethers, dioxane, and tetrahydrofuran (T~F). THF is the preferred solvent.
The reaction product IV is recovered by removing the sol-vent under high vacuum.
STEP C
To obtain the cyclopentenone V from the diketone IV, the intermediate obtained in step B is stirred for 0.5 to 2.5 hours in a buffered solution having a pH value rang-ing from about 5 to about 11, preferably from 6 to 9. The buffered solution is prepared, for example, by adding tri-ethanolamine to aqueous HCl; or an alkali metal or alk~line earth metal carbonate, bicarbonate citrate or phosphate may also be utilized for this purpose. Advantageously, a calcium or magnesium carbonate which also encompasses a commercial grade, e.gO, an oxide-carbonate such as co~mercial MgC03 containing 40 percent MgO, may be utilized. An excess wherein undissolved MgC03 is present is preferred. The cyclization of diketones derived from l-malic acid leads to cyclopentenones having the sub-stituent A0 with an ~-configuration. The use of d-malic acid derivatives affords products with the ~-configuration.

STEP D
Hydrogenation of the double bond of the cyclopentenone V involves stereochemical problems, as the resulting cyclopentanone VI must have the two substituents which are precursors of the side chains of prostaglandins in the desired configuration. For instance, the optically active intermediates I
which are useful for the synthesis of naturally occurring prostaglandins must have the substituent R in the ~-configuration and the methyl-carbonyl group which originates the lactone ring in the -configuration.
One of the main features of the process of this invention lies in the fact that the original configuration o~ t~e group AO determines the con-figuration of the products of hydrogenation. In fact, when said group has the ~-configuration, the resulting products assume the correct configuration with respect to the two adjacent chiral centers, so that the subsequent steps may lead to the desired lactone Ib. When the AO group has the ~-configura-tion, the resulting intermediates have the opposite configuration, leading to lactones of the series Ia which allow the synthesis of mirror-image forms of naturally-occurring prostaglandins. A reducing agent which is advantageously employed in step D is hydrogen gas in the presence of a noble metal or a noble metal oxide as the hydrogenation catalyst. As an example, Pd supported on barium sulfate or charcoal or PtO2 poisoned with a trace of pyridine gives excellent results. The hydrogenation is carried out in an inert organic sol-vent, preferably an aromatic solvent such as, for example, benzene, at a pressure ranging from atmospheric to 5 atmospheres pressure.
STEP E
This step involves the reduction of the keto group positioned on the cyclopentane ring of compound VI to a hydroxy group. This function in the precursors for the synthesis of naturally-occurring prostaglandins must have the -confieuration.
A further surprising result of the process is that the reduction of compound VI leads to a derivative having the required configuration. Of course, the stereo-chemistry is completely opposite if, as a starting mate-rial, a cyclopentanone compound is employed derived from an intermediate V

. , . : : .

106003~

havin~ the group A0- in the ~-configuration.
It has been found in accordance with this invention that the use of sodium borohydride in the buffer solution at a pH value ranging from 3 to 9, and preferably from 4 to 7.5 is particularly well suited for the stereo-selective reduction of the keto group. The buffer solution may be suitably prepared by using an alkali metal phosphate, citrate or monophthalate. ~he operations of steps D and E may be combined in a single step, although with-out any substantial improvement of yield, by reducing directly compound V
with an alkali metal borohydride or by catalytic hydrogenation in a lower alkanol, preferably at a higher pressure range (5-30 atmospheres) to speed up the rate of reduction of the keto group.
STEP F
Alkaline hydrolysis of compound VII followed by acylation affords the lactone of hydroxycyclopentaneacetic acid, VIII. The alkaline hydrolysis mPy be carried out according to common procedures. Alkali metal carbonates and alkali metal hydroxides in lower alkanols or in mixtures of water and water-miscible organic solvents are well suited for carrying out this opera-tion but, of course, other analogous conditions and procedures may be used for the ester cleavaee.
The temperature of the hydrolysis reaction may vary from about 0 C
to about 30 C. Acylation of the hydroxy group with simultaneous lactoniza-tion may be performed directly on the crude reaction product. Suitable acylating agents are the halides or anhydrides of lower aliphatic carboxylic acids of 2 to o carbon atoms, benzoic acid and substituted benzoic acid wherein the substituents are selected from chloro, bromo, fluoro, lower alkyl, phenyl and cyclohexyl.
The lactonization may also be carried out in a lower alkanol sat-urated with dry hydrogen chloride. In this case, compounds of formulas I, Ia and Ib are obtained wherein R is hydrogen and R is a lower carboalkoxy group. These compounds may also be obtained by cleavaee of the esters of formula VII with an alkali metal carbonate in an anhydrous lo~er alkanol medium.
_ g _ 11)60031 STEP G
The reduction of the carboxylic group in compound VIII requires the use of agents which do not affect the other carbonyl groups in the molecule.
For example, diborane is known to be more reactive toward carboxylic groups than toward ester or lactone groups.
A preferred method involves conversion of the acid functionality to a carbonyl halide, to a mixed anhydride or to a reactive amide such as the imidazolide. The conversion to a carbonyl halide is carried out by means of a halogenating agent such as, for example, SOC12 or l,l-dichloromethyl methyl ether in the presence of ZnC12. Mixed anhydrides are generally formed by reaction with a lower alkyl chlorocarbonate. The imidazolide, the acid halide or the anhydride is then reduced with an excess of sodium borohydride.
STEP H
A different path~ay is followed for preparing end compounds IX
whereln the group R0 is an ether group. In this case, the hydroxy compound VII is reacted with an agent capable of forming an ether group to give a compound of formula X wherein R is lower alkyl, benzyl, trityl, lower alkoxy-lower alkyl or tetrahydropyranyl. Reagents which may be employed for this preparation include lower alkyl halides of 1 to 6 carbon atoms, benzyl halides, trityl halides, lower ~lkanols, dihydropyran and lower alkyl-lower alkenyl ethers such as, for example, ethyl vinyl ether in the presence of an acidic catalyst.
ST~P I
Hydrolysis of above compound X under the same hydrolytic conditions as in ætep F, followed by acidification with a mild acid affords the car-boxylic compound VIII wherein R0 represents an ether group as defined under step H. The latter is reduced to the corresponding alcohol following the same conditions described under step G.
An alternative procedure for preparing the carboxylic compound VIII
wherein R0 is an ether group involves hydrolytic cleavage of compound VII
according to the conditions outlined under step E, followed by neutraliza-tion and reaction with a reagent capable of forming an ether linkage instead ` ~06iO031 of an acylating agent. Reagents which may be employed for this step are essentially those listed under step H. Lower alkyl-lower alkenyl ethers and dihydropyran are particularly well suited for this purpose.
The following additiona] description and examples further describe the invention and the manner and process of making and using it to enable the art skilled to make and use the same and set forth the best mode contemplated by the inventors of carrying out the invention.

Preparation of Compound III, l-Acetoxysuccinoyl Chloride l-Malic acid (25 g., 0.19 mole) is transformed to 1-2-acetoxysuccinic anhydride according to literature methods by refluxing it in 30 ml. of acetyl chloride. The solution of the anhydride resulting from the reaction, is cooled and an excess of l,l-dichloromethyl methyl ether (70 g., 0.57 mole) and anhydrous ZnC12 (500 mg.) is added. After refluxing for four hours, the solution is cooled. Benzene (500 ml.) is then added thereto and the solution after decantation is filtered and eYaporated in vacuo. The residue is 1-2-acetoxysuccinoyl chloride which may be purified by distilling at 75-78 C/0.05 mm. Hg ~a~ 5:- 10 (c=1% in CHC13). The yield is about 80~.
The corresponding d- and racemic compounds are prepared according to the same procedure. The dI- mixture and the optically-active benzoyloxysuccinoyl chlorides are prepared accordingly. Their yields are 80-85%. These chlo-rides are not distillable without decomposition and, therefore, they are used as such in subsequent reactions. An analytical sample of 1-2-benzoyloxysuccinoyl chloride, distilled at 140-143 C/0.5 mm. Hg, had the following microanalysis.
Analysis for C6H604C12, percent:
Calculated C, 33,83 H, 2.83 Cl, 33.28 Found C, 34.o8 H, 2.ôl C1, 33.12 Preparation of Compound I~, 1-3,6-Dioxo-4-Acetoxyoctanedioic Acid Dimethyl Ester To a vigorously stirred suspension of magne~ium (72 g., 3.0 moles) in 1000 ml. of (tetrahydrofuran) (THF) (freshly distilled from lithium 106~031 aluminum hydride), ethyl bromide (350 g., 3.2 moles) is added at such a rate as to maintain a temperature of 30-35 C. If, after addition, unreacted magnesium is present, 10 g. of ethyl bromide is added and the reaction is re~luxed for one hour. Then the water in the condenser is turned off and a stream of nitrogen is passed over the reaction to remove excess ethyl bro-mide. The solution is then cooled to -20C by an ice-acetone bath and 2500 ml. of THF is added. Then maintaining a temperature below -10 C, methyl hydrogen malonate (177 g., 1.5 moles) in 500 ml. of THF is added. After addition is complete, the solution is refluxed for two hours, then cooled to 25 C and 1-2-acetoxysuccinoyl chloride (63.6 g., 0.3 moles) is added.
After stirrine overnight, the solution is poured into 1800 ml. of lN hydrochloric acid. The THF layer is then washed with successive 500 ml.
volumes of a lM phosphate buffer (pH 6.5) until the pH of the buffer is un-changed. Drying of the organic layer (MgS04) and evaporation leaves a crude product (70 g.) which exhibits spectral properties identical to the known material. This unstable titular product is used as soon as possible. The corresponding d-derivative and the racemic mixture of enantiomers are pre-pared similarly. ~he dimethyl esters of the racemic and of the optically-active 3,6-dioxo-4-benzoyloxyoctanedioic acids are prepared under conditions essentially identical with those described for the acetoxy derivatives. The products are not purified for subsequent reactiont.

Preparation of Compound V, 5-Acetoxy-2-Carbomethoxy-3-Oxo-l-~ lo~enteneacetic Acid Methyl Ester A solution of 70 g. of the dimethyl ester of 1-3,6-dioxo-~-acetoxyoctanedioic acid (IV) in 500 ml. of ether is added to a vigorously stirred suspension of 30 g. of MgC03 (commercial product containing ~0 per-cent MgO) in 1000 ml. of H20 Almost immediately the pH of the solution becomes 6.o-6.5 nd remains in this range throughout the reaction. After thirty minutes, the reaction is filtered and the ether and aqueous layers separated. The ether layer is washed with 100 ml. of lM phosphate buffer (pH 7). The combined aqueous layers are acidified with concentrated hydro-chloric acid, saturated with sodium chloride and extracted with three 500 ml.

volumes of ethyl acetate. Drying (MgS04) and evaporation of the ethyl acetate gives 55 g. of oil which quickly crystalli~es. Recrystallization from carbon tetrachloride gives the titular product (41 g., 50 percent yield from l-2-acetoxysuccinoyl chloride) of white crystals identical in every way with known material. Pursuant to the same procedure, the d-acetoxy-octanedioic acid derivative gives a cyclopentene derivative of formula V
wherein the acetoxy group has the ~-orientation. The dl-acetoxy and benzoyloxy analogs and the enantiomeric d- and 1- benzoyloxyoctanedioic acid analogs, are prepared according to the same procedure.

Preparation of Compound VI, 2-Carbomethoxy-3-Oxo-5--Acetoxycyclopentaneacetic Acid Methyl Ester The cyclopentene acid, V, (9.5 g.) is dissolved in 180 ml. of benzene and the solution is hydrogenated at room temperature and atmospheric pressure in the presence of 0.5 g. of palladiated barium sulfate. When the theoretical amount of hydrogen is adsorbed, catalyst is filtered off and the solution is evaporated to dryness under vacuum, yielding 9 g. (95%) of the methyl ester of 2-carbomethoxy-3-oxo-5-acetoxycyclopentaneacetic acid with the required stereochemical configuration. The compound is a rather unstable solid, melting at 54 C; [~]d5:17.8 (C=1.017% in CHC13).
Analysis for C12H1607, percent:
Calculated C, 52.94 H, 5.72 Found C, 53.14 H7 5.91 -I.R., ~.M.R. and mass spectral data are in agreement with the assigned structure. The use of different catalysts such as Pd, PtO2 and Rh has little effect on the final yields. The same reaction conditions are suitable for preparing the racemate, the mirror image isomer and all the corresponding 5-benzoyloxy derivatives.

Preparation of Compound VII, 5-Acetoxy-2-Carbomethoxy--3-Hydroxycyclopentaneacetic Acid Methyl Ester The cyclopentanone VI (8.6 g.), obtained according to the previous example, is dissolved in 50 ml. of methanol and added to 500 ml. of a phos-phate buffer adJusted to a pH of 5.3. Then 20 ml. of an aqueous solution containing an excess of sodium borohydride (1.25 g.) is added at 5C. After two hours at room temperature, 200 ml. of water is added to the reaction mix-ture which is then extracted several times with ethyl acetate. The combined organic layers are dried on MgS04 and then evaporated to dryness giving 8.4 g. (98%) of crude methylester of 5-acetoxy-2-carbomethoxy-3-hydroxy-cyclopentaneacetic acid. This product examined by gas chromatography exhibits an 80% purity. The product which may be further purified by column chromat-ography has all the substituent groups with the desired orientation. The compound may not be distilled without decomposition. The principal absorp-tion peaks in the N.M.R. spectrum in CDC13 occur at the following frequencies expressed in ~ units:
2.05 (3H, singlet), 3.65 (3H, singlet), 3.72 (3H, singlet) 4.30-4.70 (lH, multiplet), 5.18-5.43 (lH, multiplet).
The I.R. spectrum (neat) shows characteristic bands at the follow-ing frequencies:
3~50, 2920, 1730, 1725, 1710, 1435, 1370, 1270, 1240, 1200, 1160, 1040, 1020, 950, 890 cm. 1 Analysis calculated for C12H1807, percent:
Calculated C, 52.55 H, 6.60 Found C, 52.16 H, 6.59 The racemic mixture, the mirror image compound and all corresponding benzoyloxy derivatives are prepared by following essentially the same pro-cedure.
The methyl ester of 5-acetoxy-2-carbomethoxy-3-hydroxy-cyclo-pentaneacetic acid may be prepared in a 60% yield by reducing directly the methyl ester of 5-acetoxy-2-carbomethoxy-3-oxo-1-cyclopenteneacetic acid, VI, with sodium borohydride. The reaction conditions are essentially identical with those described above.
An alternative direct method involves stirring for 5 hours in an autoclave under 15 atmospheres of hydrogen the methyl ester of 5-acetoxy-2-carbomethoxy-3-oxo-1-cyclopenteneacetic acid (200 mg.) dissolved in 15 ml.

1060C~3~
of methanol in the presence of 20 mg. o~ PtO2. Removal of the catalyst and of the solvent gives 200 mg. of a crude oil which contains about 60~ of the desired isomer (determined by gas chromatography).

Preparation of Compound VIII, Lactone of 3-Acetoxy-2-Carboxy-5-Hydroxycyclopentaneacetic Acid The methyl ester of 5-acetoxy-2-carbomethoxy-3-hydroxy-cyclopentaneacetic acid (95 mg.) in one milliliter of methanol is added at O C under a nitrogen atmosphere to a solution of 180 mg. of potassium hydroxide in 3 ml. of methanol. After standing at room temperature for four hours, 1.2 g. of Amberlite CG 120 ~ is added and the mixture is stirred for two minutes. After filtration of the solid the methanol is evaporated off.
To the residue, 1 ml. of acetyl chloride is added and the mixture is allowed to stand at room temperature for three hours. The acetyl chloride excess is evaporated off at 30C and the residue is taken up with water, from which the lactone of 3-acetoxy-2-carboxy-5-hydroxycyclopentaneacetic acid crystallizes out. Yield 54 mg. (67%).
The product when crystallized from water melts at 205-206 C[a]d5:
-90.1 (c=1.1% in pyridine).
Analysis calculated for CloH12O6, percent:
Calculated C, 52.63 H, 5.30 Found C, 52.80 H, 5.~0 The N.M.R., I.R. and mass spectral data are in accordance with the lactonic structure, VIII, (R=CH3CO), i.e., a compound of the formula Ib wherein R is acetyl and R is COOH. The same lactone VIII is obtained by employing as the starting material the methyl ester of 5-benzoyloxy-2-carbomethoxy-3-hydroxy-cyclopentaneacetic acid. The above described conditions are suitable also for preparing the corresponding racemate and the mirror image enantiomers falling respectively within the scope of formulas I and Ia, by utilizing the proper starting materials.
The acid cleavage of the methyl ester, VII, is carried out by dis-solving the compound (5 g.) in 20 ml. of methanol and adding the solution to 70 ml. of methanol saturated with dry hydrogen chloride. The reaction mix-' 106~)03~
ture is maintained at 0C for eight hours, then the solvent is evaporated off. The residue is purified by crystallization from ethyl ether. The product obtained in a L5 percent yield is the lactone of 2-carbomethoxy-3,5-dihydroxycyclopentaneacetic acid, i.e., compound Ib wherein R is hydrogen and R is carbomethoxy. 25 The product melts at 103C7[~]d :-15.9 (c=1.95% in CHC13) Analysi5 calculated for CgH1205, percent:
Calculated C, 53.99 H, 6.o4 Found C, 54.26 E, 6.16 The I.R., ~.M.R. and mass spectrometry data confirm the assigned structure.
The above lactone is also obtained, in a 70% yield, by cleavage of the ester VII with K2C03 in anhydrous methanol at room temperature.

Preparation of Compound IX, y-Lactone of 3-~cetoxy-2-Hydroxymeth~1-5-Hydroxycyclopentaneacetic Acid The lactone of 3-acetoxy-2-carboxy-5-hydroxycyclopentaneacetic acid, VIII (410 mg.), obtained pursuant to Example 6 is dissolved in 10 ml. of dichloromethane under a nitrogen atmosphere and to the so-obtained solution cooled to -10C, 200 mg. of triethylamine is added followed by 216 mg. of ethyl chlorocarbonate in 5 ml. of dichloromethane. After stirring for one hour at a temperature between -15C and -10C, the solution is added to 150 mg. of sodium borohydride in 30 ml. of dry ethanol at -30C. The mixture is stirred at a temperature between -30C and -10C for one hour, then is poured into 30 ml. of water containing 0.005 mole of monosodium citrate. The aqueous solution is Pxtracted with ethyl acetate and the organic layer, after washing with aqueous sodium bicarbonate and water, is dried over MgS0~ and evaporated to give 376 mg. (98%) of an oily product which is the lactone of formula IX wherein R is acetyl. Specific rotation, I.R. and N.M.R. data confirm that this product is identical with the intermediate described by Corey et al., J.A.C.S. 927 397 (1970). The same product may be prepared by reducing with sodium borohydride the chloride of the acid of formula VIII.
~he acid is converted to the corresponding chloride by heating at 60C for 5 minutes with SOC12 in the presence of traces of dimethylformamide or by ~, ' ", .

reaction with l,l-dichloromethyl methyl ether and ZnC12. Evaporation of the volatile materials affords a crude product which is directly reacted with NaBH4 in dry ethanol. The yield is of about 95%.
The corresponding racemate and mirror image compound are prepared by pursuing essentially the same procedures.

Preparation of Compound X, 5-Acetoxy-2-Carbomethoxy-3-Tetrahydropyranyloxycyclopentaneacetic Acid Methyl Ester The methyl ester of 5-acetoxy-2-carbomethoxy-3-hydroxycyclo-pentaneacetic acid of formula VII (5.8 g.) is dissolved in 50 ml. of anhy-drous benzene and to the obtained solution 70 mg. of p-toluenesulfonic acid in 30 ml. of anhydrous benzene are added followed by 1.87 g. of 2,3-dihydro-pyran. After standing for one hour at the room temperature the solution is poured into aqueous sodium bicarbonate. After extraction with dichloro-methane the organic solution is dried over Na2S04 and evaporated to give 6.9 e. (90%) of an oily product which is the methyl ester of 5-acetoxy-2-carbomethoxy-3-tetrahydropyranyloxycyclopentaneacetic acid. The principal absorption peaks in the N.M.R. spectrum in CDC13 occur at the following frequencies expressed in ~ units:
1.6 (6H, multiplet), 2.02 t3H, singlet), 3.65 (3H, singlet), 3.7 (3H5 sing-let~ 4.3-4.8 (2H, multiplet) 5-5.35 (lH, multiplet) The I.R. spectrum (neat) shows characteristic bands at the following fre-quencies:
2930, 1740, 1440, 1380~ 1240, 1200, 1170, 1135, 1080, 1030, 970, 870, 820 cm. 1 Analysis calculated for C17H2608, percent:
Calculated C, 56.97 H, 7.31 Found C, 56.65 H, 7.43 The assigned structure is supported also by U.V. and mass spectral data. The racemate, the mirror image enantiomer and the benzoyloxy derivatives are prepared pursuant to the same methods.

~06003~

Transformation of Compound X to Compound IX
The methyl ester of 5-acetoxy-2-carbomethoxy-3-tetrahydropyranyl-oxycyclopentaneacetic acid (0.95 g.) in 15 ml. of dioxane is added under a nitrogen atmosphere to a solution of 0.75 g. of KOH in 15 ml. of water.
After standing at room temperature overnight, the mixture is washed with ethyl ether and the aqueous phase is acidified with 5 g. of citric acid in 50 ml. of ice water. After four extractions with ethyl acetate, the combined organic extracts are dried and evaporated to dryness, giving 0.7 g. (69%) of the lactone of formula VIII ~herein R is 2-tetrahydropyranyl, i.e., compound Ib wherein R is 2-tetrahydropyranyl and Rl is COOH; m.p. 156 C.
The compound VIII is then converted in a 95% yield to the cor-responding compound of formula IX wherein R is 2-tetrahydropyranyl by fol-lowing essentially the same procedure described in Example 7. The ~.M.R. and I.R. spectral data of the product obtained are in agreement with the assigned structure.
Analysis calculated for C13H2005, percent:
Calculated C, 60.92 H, 7.87 Found C, 60.75 H, 7.77 Cleavage of the ester, X, with sodium methoxide or potassium car-bonate in anhydrous methanol affords a lactone of formula Ib wherein R is tetrahydropyranyl and R is COOCH3 in a 70% yield.

Transformation of Compound VII to VIII
Five hundred milligrams of the methyl ester of 5-acetoxy-2-carbomethoxy-3-hydroxycyclopentaneacetic acid (VII) are h~drolyzed to the lactone of 2-carboxy-3,5-dihydroxycyclopentaneacetic acid by following the same conditions described in the first part of Example 6. After addition of 7 g. of Amberlite CG 120 ~ , the residue is crystallized from ethyl acetate, giving 243 mg. (71%) of the pure product (VIII, R=H) which melts at 152 C;[a] d ~53 (c=0-85% in pyridine). The compound obtained is then re-acted with 100 mg. of 2,3-dihydropyran in the presence of p-toluenesulfonic , . ~ , . . ~, ............... .. .

106003~
acid (15 mg.) pursuant to the procedure described in Example 8, to give 288 mg. (83%) of the lactone VIII, wherein R is 2-tetrahydropyranyl .. . ' . ... . '. . ; ' . : :

Claims (2)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVF.
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for preparing a compound of the group having the formula and its optically active forms wherein R represents an alkanoyl radical of 2 to 8 carbon atoms; and R1 repre-sents a -CH2-OH group, which comprises (1) reacting substantially one molar proportion of an alkanoyloxy succinoyl chloride with substantially five molar proportions of a salt of the formula wherein Y represents a -COOR2 group wherein R2 is a lower alkyl and X is a monovalent magnesium cation selected from the groups Mg Br?, MgCl? and Mgl?
whereby a 3,6-dioxo-4-acyloxyoctanedioic acid ester is formed, (2) cyclizing the last named by heating it in an aqueous solution at a pH of about 5 to 11 to give a 5-alkanoyloxy-2-carbo(lower alkoxy)-3-oxo-1-cyclopenteneacetic acid ester, (3) hydrogenating the cyclopentene ring to cyclopentane and the oxo group to hydroxy, (4) cyclizing the so-obtained alkanoyloxycyclopentaneacetic acid derivative by alkaline hydrolysis and acy]ation to the corresponding lac-tone of preceding formula I, Ia or Ib wherein R1 is a carboxy group and R is a (C2-C8)alkanoyl, (5) converting the carboxylic group to a mixed anhydride group by reaction with a lower alkyl chlorocarbonate or to an acid chloride group by reaction with SOCl2 and (6) reducing the mixed anhydride group or the acid chloride group with excess sodium borohydride to give a gamma lactone of 3-alkanoyloxy-2-hydroxymethyl-5-hydroxycyclopentaneacetic acid.
2. The process of claim 1 wherein the alkanoyloxy-succinoyl chloride of step (1) is 1-2-acetoxysuccinoyl chloride and the salt is whereby 1-3,6-dioxo-4-acetoxyoctanedioic acid dimethyl ester is formed, (2) cyclizing the last named compound by heating it in aqueous solution at a pH
of about 6 to 9 to give 5-acetoxy-2-carbomethoxy-3-oxo-1-cyclopentene-acetic acid methyl ester, (3) hydrogenating the cyclopentene ring to cyclopentane with hydrogen in the presence of a noble metal or a noble metal oxide hydro-genation catalyst, (4) hydrogenating the keto group to a hydroxy group with sodium borohydride in an aqueous solution buffered to a pH of about 3 to about 9 to give the methyl ester of 3-acetoxy-2-carbomethoxy-3-hydroxycyclopentane-acetic acid, (5) cyclizing the last named compound via alkaline hydrolysis and acylating the hydroxy group with acetyl chloride to give the lactone of 3-acetoxy-2-carboxy-5-hydroxycyclopentaneacetic acid, (6) converting the carboxy group to a mixed anhydride group by reaction with excess ethyl chloroformate or to an acid chloride group by reaction with SOCl2 and reducing the mixed anhydride group or the acid chloride group with excess sodium borohydride to give the gamma lactone of 3-acetoxy-2-hydroxymethyl-5-hydroxycyclopentaneacetic acid.
CA221,374A 1974-03-01 1975-03-06 Intermediates for prostaglandins Expired CA1060031A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44710374A 1974-03-01 1974-03-01

Publications (1)

Publication Number Publication Date
CA1060031A true CA1060031A (en) 1979-08-07

Family

ID=23775005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA221,374A Expired CA1060031A (en) 1974-03-01 1975-03-06 Intermediates for prostaglandins

Country Status (11)

Country Link
JP (1) JPS5843395B2 (en)
BE (1) BE826149A (en)
CA (1) CA1060031A (en)
CH (2) CH605886A5 (en)
DE (1) DE2508281C3 (en)
DK (1) DK153946C (en)
FR (1) FR2264026B1 (en)
GB (1) GB1494758A (en)
IT (1) IT1033236B (en)
NL (1) NL7502395A (en)
SE (1) SE417513B (en)

Also Published As

Publication number Publication date
FR2264026B1 (en) 1978-04-21
DK75575A (en) 1975-11-03
DK153946B (en) 1988-09-26
DE2508281A1 (en) 1975-09-04
SE417513B (en) 1981-03-23
DE2508281B2 (en) 1979-08-23
JPS50123656A (en) 1975-09-29
FR2264026A1 (en) 1975-10-10
DE2508281C3 (en) 1980-04-30
CH605886A5 (en) 1978-10-13
GB1494758A (en) 1977-12-14
SE7502311L (en) 1975-09-02
DK153946C (en) 1989-02-06
IT1033236B (en) 1979-07-10
BE826149A (en) 1975-06-16
NL7502395A (en) 1975-09-03
JPS5843395B2 (en) 1983-09-27
CH605885A5 (en) 1978-10-13

Similar Documents

Publication Publication Date Title
US4153615A (en) Method of producing coloring agents
CA1060031A (en) Intermediates for prostaglandins
US4018797A (en) Intermediates for prostaglandins
US4568762A (en) 4-Methyl-2-oxo-cyclopentylidene acetic acid and esters thereof
US4159386A (en) Synthesis of cyclopentanol
CA1173051A (en) Total synthesis of 1rs,4r,5rs-4-(4,8- dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3, 8-dioxabicyclo¬3.2.1| octane-1-acetic acid
US2793233A (en) Hormone intermediate and production thereof
US4170596A (en) Novel monoesters of cis-cyclopentenediol, process for preparation thereof, and process for preparation of lactones from the monoesters
US4958037A (en) Precursors and synthesis of methyl-9-oxo-11α, 16-dihydroxy-16-vinyl-5-cis-13-trans-prostadienoates
JPH06256334A (en) Production of cis-whiskey lactone
US4044005A (en) Peroxides of 2-oxo-cyclopenta[b]furans
US4312812A (en) Process for the manufacture of cholesterol derivatives
US4032520A (en) Synthesis of cyclopentanol
US4005110A (en) 2H-Cyclopenta(b)furan-2-ones
US3892814A (en) Cyclopropane derivatives
JPS5921864B2 (en) Fluoroprostaglandins and their production method
US4021446A (en) 4-Benzyloxymethyl-5-[(1-pyrrolidinyl-carbonyl)-methyl]-1,3-cyclopentylene-diacetate compounds
US4208533A (en) Synthesis of cyclopentanol
US4074045A (en) 2H-cyclopenta b!furan-2-ones and process for preparation
US3929853A (en) Preparation of cyclopentane derivatives
US4059577A (en) Synthesis of cyclopentanol
JPS6229568A (en) Precursors and synthesis of methyl-9-oxo-11 alpha,16-dihydroxy-16-vinyl-5-cis-13-trans-prostadienoates
US4866205A (en) Prostaglandin intermediates
GB1561548A (en) Chroman derivatives
US4707555A (en) Prostaglandin intermediates